What is the price target for CHRD stock?
26 analysts have analysed CHRD and the average price target is 159.56 USD. This implies a price increase of 9.58% is expected in the next year compared to the current price of 145.6.
NASDAQ:CHRD • US6742152076
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHORD ENERGY CORP (CHRD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-22 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-04-17 | Roth Capital | Reiterate | Buy -> Buy |
| 2026-04-13 | Truist Securities | Maintains | Buy -> Buy |
| 2026-04-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-31 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-03-27 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2026-03-24 | Truist Securities | Initiate | Buy -> Buy |
| 2026-03-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-03-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-03-05 | UBS | Maintains | Buy -> Buy |
| 2026-03-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-14 | Citigroup | Downgrade | Buy -> Neutral |
| 2026-01-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-09 | UBS | Maintains | Buy -> Buy |
| 2025-12-12 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-21 | William Blair | Initiate | Outperform |
| 2025-11-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-12 | UBS | Maintains | Buy -> Buy |
| 2025-10-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.897B 6.85% | 5.251B 34.76% | 4.877B -7.12% | 5.161B 5.82% | 5.055B -2.05% | 5.279B 4.43% | 5.36B 1.53% | 5.306B -1.01% | |
| EBITDA YoY % growth | 1.875B -3.80% | 2.28B 21.63% | 2.208B -3.16% | 2.35B 6.43% | 2.46B 4.68% | 2.607B 5.98% | 2.554B -2.03% | 2.554B | |
| EBIT YoY % growth | 1.276B -19.19% | 1.172B -8.12% | 737.814M -37.06% | 621.74M -15.73% | 752.37M 21.01% | 791.19M 5.16% | N/A | N/A | |
| Operating Margin | 32.74% | 22.32% | 15.13% | 12.05% | 14.88% | 14.99% | N/A | N/A | |
| EPS YoY % growth | 20.07 -28.58% | 16.68 -16.89% | 9.46 -43.29% | 9.02 -4.66% | 11.05 22.47% | 12.71 15.05% | 11.08 -12.81% | 12.59 13.64% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.75 -31.94% | 4.25 137.19% | 3.71 57.90% | 3.36 162.23% | 3.26 18.71% | 2.97 -30.07% | 3.20 -13.77% | 3.42 1.78% | 4.10 25.55% | 3.93 32.53% | 4.13 29.09% | 4.38 28.30% |
| Revenue Q2Q % growth | 1.212B -0.25% | 1.385B 17.32% | 1.326B 1.06% | 1.282B 9.63% | 1.224B 0.99% | 1.225B -11.55% | 1.25B -5.73% | 1.267B -1.17% | 1.255B 2.53% | 1.235B 0.82% | 1.256B 0.48% | 1.271B 0.32% |
| EBITDA Q2Q % growth | 625.27M -9.04% | 737.97M -14.81% | 700.49M -44.97% | 673.67M -56.81% | 669.71M 7.11% | 663.7M -10.06% | 683.22M -2.47% | 702.91M 4.34% | 738.65M 10.29% | 749.54M 12.93% | 760.42M 11.30% | 770.44M 9.61% |
| EBIT Q2Q % growth | 239.78M -28.97% | 284.71M 104.08% | 238.4M 39.29% | 229.82M 156.86% | 251.57M 4.92% | 239.87M -15.75% | 251.14M 5.34% | 269.15M 17.11% | 265.13M 5.39% | 234.16M -2.38% | 237.69M -5.36% | 255.11M -5.22% |
All data in USD
26 analysts have analysed CHRD and the average price target is 159.56 USD. This implies a price increase of 9.58% is expected in the next year compared to the current price of 145.6.
CHORD ENERGY CORP (CHRD) will report earnings on 2026-05-05, after the market close.
The consensus EPS estimate for the next earnings of CHORD ENERGY CORP (CHRD) is 2.75 USD and the consensus revenue estimate is 1.21B USD.
The consensus rating for CHORD ENERGY CORP (CHRD) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.